West recently announced that it is forming a partnership with Swissfillon AG in which Swissfillon will provide fill-finish capabilities to customers using West’s proprietary SmartDose drug delivery platform. The partnership, which West announced last month at PharmaPack 2019 in Paris, will enable West to deliver filled Daikyo Crystal Zenith cartridges for the SmartDose wearable injector. […]
Business/Financial News
Senseonics shares dip on Q4 sales miss, lowered guidance
Shares in Senseonics (NYSE:SENS) fell slightly today after the diabetes-focused device maker posted fourth quarter and full year 2018 earnings that beat loss-per-share consensus but missed sales expectations and lowered its guidance for the 2019 fiscal year. The Germantown, Md.-based company posted losses of $7.3 million, or 4¢ per share, on sales of $7.2 million for […]
Pops! Diabetes Care launches blood glucose monitoring system
Pops! Diabetes Care announced today the commercial launch of its blood glucose monitoring system. The Minneapolis-based company’s device won FDA clearance in December last year. The device can be attached directly to the back of a mobile phone and interacts with the user through a coaching app. The Pops! One system also allows users to […]
Livongo preps for $1B IPO
Livongo Health is preparing for a $1 billion initial public offering this year, according to a new report from The Wall Street Journal. The IPO for the Mountain View, Calif.-based diabetes-focused digital health company is set to drop in the third quarter of this year, according to the report. Livongo tapped Morgan Stanley, Goldman Sachs […]
Ocular Therapeutix posts mixed Q4 results
Shares in Ocular Therapeutix (NSDQ:OCUL) fell in premarket activity today after the company posted mixed fourth-quarter results. The Bedford, Mass.-based company posted a net loss of -$17.4 million, or -42¢ per share, on sales of $504,000 for the three months ended Dec. 31, for sales growth of 3.5% compared with the same period last year. Earnings […]
InfuSystem reports Q4, FY18 financial results
Shares in InfuSystem (NYSE:INFU) ticked up slightly today after the company reported its fourth-quarter and full-year financial results. The Michigan-based company posted a net loss of -$275k, or -1¢ per share, on sales of $17.6 million for the three months ended Dec. 31. Sales were down 7% compared to the same period last year. For the […]
FDA approves J&J’s nasal spray for treatment-resistant depression
The FDA has approved Johnson & Johnson‘s (NYSE:JNJ) esketamine nasal spray for people living with treatment-resistant depression. The company’s product, Spravato, is an intranasal formulation of ketamine – a horse tranquilizer that is also known as Special K. The drug won support for approval from an FDA advisory committee earlier this year. Spravato is the […]
Valeritas posts mixed Q4 results
Valeritas (NSDQ:VLRX) posted its fourth-quarter and full-year financial results today, missing earnings estimates but topping revenue expectations on Wall Street. The Bridgewater, N.J.-based company posted a net loss of -$11.9 million on sales of $6.89 million for the three months ended Dec. 31, for sales growth of 19% compared with the same period last year. Earnings […]
Pacira to acquire Myoscience in $220m deal
Pacira Pharmaceuticals (NSDQ:PCRX) said today that it has signed a deal to acquire Myoscience and its pain relief device for up to $220 million. Myoscience’s iovera system is designed to safely freeze nerves while protecting surrounding tissue. As part of the deal that is slated to close by early April, Pacira plans to incorporate the iovera […]
Teva launches generic for Pfizer’s Flector pain patch
Teva (NYSE:TEVA) said last week that it launched a generic version of Pfizer‘s (NYSE:PFE) Flector diclofenac epolamine patch. Using a nonsteroidal anti-inflammatory drug, the topical patch is designed to treat acute pain due to minor strains, sprains and contusions. Pfizer’s Flector patch garnered annual sales of $123 million in the U.S. as of Dec. 2018, according […]